aortic stenosis, aortic regurgitation
Conditions
Interventions
None listed
Sponsors
Department of Anesthesiology and Critical Care, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult patients undergoing TAVI at our hospital who have given written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of esCCO/ICO ratio and FloTrac CCO/ICO ratio before and after TAVI | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation coefficient between esCCO and ICO before and after TAVI | — |
Countries
Japan
Contacts
Public ContactDaiki Shorin
Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University Department of Anesthesiology and Critical Care
Outcome results
None listed